Showing all 7 results

Show sidebar

ELBONIX 50 MG

COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL

ELOPAG 25 MG

 Elopag Tablet Eltrombopag Olamine 25 mg Everest Pharmaceuticals Ltd. Indications Eltrombopag Olamine is indicated in Chronic Immune (Idiopathic) Thrombocytopenia, Chronic Hepatitis

HEPANIB 200 MG

 Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd. Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with

LAPANIX 250 MG

LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase

PALBOCENT 125 MG

DESCRIPTION Palbocent Palbociclib 125 mg Capsules Incepta Pharmaceuticals Limited Indications Palbociclib is a kinase inhibitor indicated for the treatment of

PALBONIX 125 MG

DESCRIPTION Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:

PANOVIR

 Panovir Tablet Sofosbuvir + Velpatasvir 400 mg+100 mg Incepta Pharmaceuticals Ltd. Indications Sofosbuvir and Velpatasvir combination is indicated for the treatment